======= B3GALT4 =======
== Gene Information ==
* **Official Symbol**: B3GALT4
* **Official Name**: beta-1,3-galactosyltransferase 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8705|8705]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O96024|O96024]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=B3GALT4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20B3GALT4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603095|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Involved in GM1/GD1B/GA1 ganglioside biosynthesis. {ECO:0000269|PubMed:9582303}.
|Galactosyl T|
|ganglioside galactosyltransferase activity|
|UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity|
|ganglioside biosynthetic process|
|ganglioside metabolic process|
|acetylgalactosaminyltransferase activity|
|glycosphingolipid biosynthetic process|
|ceramide biosynthetic process|
|glycolipid biosynthetic process|
|glycosphingolipid metabolic process|
|ceramide metabolic process|
|sphingolipid biosynthetic process|
|glycolipid metabolic process|
|liposaccharide metabolic process|
|membrane lipid biosynthetic process|
|sphingolipid metabolic process|
|membrane lipid metabolic process|
|protein glycosylation|
|macromolecule glycosylation|
|glycosylation|
|glycoprotein biosynthetic process|
|glycoprotein metabolic process|
|amide biosynthetic process|
|lipid biosynthetic process|
|carbohydrate derivative biosynthetic process|
|Golgi membrane|
|cellular amide metabolic process|
|cellular lipid metabolic process|
|Golgi apparatus|
|endoplasmic reticulum|
|carbohydrate derivative metabolic process|
|lipid metabolic process|
|organonitrogen compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-2.03|
|[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.82|
|[[:results:exp145|PNU96415E 10μM R03 exp145]]|-1.78|
|[[:results:exp406|Thalidomide 20μM R07 exp406]]|1.81|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.526|
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|1/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4604
* **Expression level (log2 read counts)**: 1.72
{{:chemogenomics:nalm6 dist.png?nolink |}}